JEFFREY FREDERICK: Open Payments
NPI 1093743957 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 17 payments from 5 companies in 2025. Trend: 2023 $475 · 2024 $356 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $177 |
| GENZYME CORPORATION | 5 | $137 |
| Optinose US, Inc. | 3 | $74 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
Products named: DUPIXENT, Xhance, NUCALA, TEZSPIRE.
Industry payments across OK — which companies pay providers there.
